U.S. stocking partner for VapoCept30 capsules · 30 days665.5 mg declared, 7 names60-day window from purchase
VapoCeptVapoceptdailySee the packs

About this site

This is a stocking partner's product-information site. That is a conflict of interest, it is stated at the top of this page rather than the bottom, and the rules below are how we try to write around it.

Revised By VapoCept Editorial DeskReviewed by Dr. Mary Cunningham, neuropsychologistReading time 10 min

Quick answer

Published by Vapoceptdaily, U.S. stocking partner for VapoCept. We sell the product and we benefit if you buy it.

Every figure here is either the seller's own published number, a citation from a source we opened, or arithmetic shown in public so it can be rechecked.

Review

Who reviews the VapoCept pages on this site

Dr. Mary Cunningham is a neuropsychologist and reviews the pages on this site before they are published: the product pages, the panel and claim pages, the cautions and every journal post. The VapoCept Editorial Desk writes them; Dr. Mary Cunningham checks what they say about memory, attention and safety, and a page is not published until the reviewer’s questions are answered.

A review is a check on the page. It is not a consultation, it is not an endorsement of VapoCept, and it does not predict what the capsule will do for you. How we work sets out where it sits among the other steps.

Dr. Mary CunninghamNeuropsychologist · reviewer for vapoceptdaily.com
Plainly

Who publishes this

Publisher
Vapoceptdaily
Role
U.S. stocking partner for VapoCept
Market
United States
Order desk
Listed in the footer — tracking, changes, refunds
Website contact
Email address in the footer — pages, typos, privacy, press
Hours
Monday to Friday, 9:00am to 5:00pm Eastern Time
Office
530 Seventh Avenue, Floor 10, New York, NY 10018, USA
Returns
111 8th Avenue, Floor 7, New York, NY 10011, USA
Editorial
VapoCept Editorial Desk
Reviewer
Dr. Mary Cunningham, neuropsychologist
Last reviewed
September 30, 2026

The conflict, stated

We sell this product. A site that sells something and also assesses it has an obvious incentive problem, and no amount of careful writing removes it. What we can do is show the working, cite what we read, publish what we could not verify, and keep the arithmetic in public where anyone can check it. Read everything here with that in mind.

Eight of them

The rules this site is written under

  1. No invented facts. Where something was not supplied, this site says it was not supplied rather than filling the gap. On this build that list runs to ten items.
  2. Provenance is stated. The milligram figures here came from a written brief rather than a photographed panel, and every page carrying them says so.
  3. The label wins over the brief. Where the two disagree — and on the claim wording they disagree substantially — the artwork is authoritative and the conflict is published.
  4. No study is cited unless it was opened. No identifier on this site was written from memory.
  5. No fabricated testimony. The seller's review figures are published as the seller's, audited, and emitted in no schema.
  6. Every choice favours the product. Lowest studied dose, nominal salt ratios, no absorption penalty. If the conclusion survives all three it is not a conclusion about our method.
  7. No verdict we are not entitled to reach. We set out the regulatory framework on the claim page and stop short of ruling, because FDA has not ruled and we are not FDA.
  8. Corrections carry dates. When we are wrong we say so on the page, not in a changelog nobody reads.
The other list

What this site will not do

  • Claim the product treats, prevents or cures anything.
  • Publish a before-and-after, a stock photograph of a person presented as a customer, or a quotation attributed to someone we cannot name.
  • Publish a countdown timer, a fake stock counter or a “seventeen people are viewing this” notice.
  • Describe a certificate we have not seen.
  • Estimate a shipping cost, a delivery window or a price that was not published.
  • Present the reconstructed panel as a transcription.
  • Tell you the FDA has ruled on a phrase it has not ruled on.
  • Pretend the arithmetic on the capsule count page is anything other than what it is.

The sixth and seventh are specific to this build, and both are temptations we had to actually resist rather than rules we never came close to breaking.

Sources

Where the numbers came from

The seven amounts
The seller's written brief, which presents them as the product's published panel. No panel artwork was supplied.
The claim wording
Read off the two supplied marketing images of the front of the bottle.
The delivered weights
Molecular weights from the NIST Chemistry WebBook, and the 2:1 stoichiometry from PubChem CID 76045315. Arithmetic, shown on the salt and base page.
The Daily Values
The FDA's Daily Value reference table, cross-checked against the NIH Office of Dietary Supplements factsheets.
The studied doses
The papers listed in the references block of the relevant pages. Every one was opened.
The regulatory material
21 CFR 101.93, the FDA Small Entity Compliance Guide, the 2000 final rule, FDA's substantiation guidance and the FTC Health Products Compliance Guidance.
The prices
The seller's brief. Published as given.
The review figures
The seller. Published as the seller's, with an audit.

The panel and its provenance →The arithmetic →

The open list

What we could not verify

Five things came up during this build that a reader might expect to see used as evidence and that are not used, because we could not stand them up.

A human trial of the 2:1 arginine AKG
The best-known AAKG trial used a 1:1 salt at 12 g a day. We found no trial of the 2:1 form, so the 2:1 entry on this label does not inherit that evidence on this site.
A peer-reviewed human trial of citrulline on cognition
We found none. The only human work we could open is a postgraduate thesis reporting no significance against placebo.
A general capsule fill capacity
It would have made a neat argument about why a gram dose cannot fit in a capsule. We could not find a citable general figure, so that argument is made qualitatively and nothing rests on it.
A controlled trial on arginine and herpes outbreaks
Widely discussed, and we could not verify it. It is flagged on the cautions page as a concern people raise rather than as a finding.
Calcium carbonate as a capsule filler specifically
Our source establishes its use as a diluent and bulking agent in tablets and coatings. It does not say capsule filler, so neither do we.

Each of those would have made an argument easier. Using them anyway is the thing this site exists not to do.

Brief against artwork

The five conflicts

The written brief and the supplied images disagree in five places. All five are published rather than resolved quietly.

What the product claims to do
The brief describes the claims as “daily mental clarity, sustained energy, cognitive well-being as printed”. The front of the bottle, in both supplied images, reads CLINICAL MEMORY RESTORATION. Those are not the same claim, and the one on the bottle is the stronger of the two by a wide margin. This site publishes the bottle's wording, because that is what a buyer holds.
Whether the FDA disclaimer appears
Neither supplied image shows the disclaimer that US rules require alongside a structure/function claim, and neither shows an asterisk on the claim line that would link to one. We are not saying it is absent from the product: we were given two marketing renders of the front of the bottle and no back panel, so we cannot see where it might be. We are saying we could not find it in what we were given.
Where the milligram figures come from
The brief supplies a typed list of seven ingredients with milligram amounts, and refers to “the published panel”. No panel artwork was supplied. Every figure on this site therefore comes from the brief and is attributed to the brief, not transcribed from a document we have seen.
How many ingredients the marketing shows
The brief lists seven. Both supplied listing images show six molecule callouts, omitting L-Citrulline Malate. A missing callout is a design decision rather than a labelling fault, and it is the kind of small inconsistency worth noticing on a page that asks you to count things.
What the sales page and the bottle each say about dose
The brief gives “One capsule daily with an 8 oz glass of water” and both listing images print “One capsule with water”. These agree, which is worth saying in a list of disagreements.

The first is the one that shapes this site. A brief describing “cognitive well-being” and a bottle reading “clinical memory restoration” are selling different things, and the buyer only ever sees one of them.

The claim, in full →

Please do

Telling us we are wrong

If a figure here is wrong, a citation does not say what we say it says, or a page has gone out of date, write to the editorial inbox and say which page and which sentence.

The most valuable correction anyone could send us on this build is a photograph of the actual Supplement Facts panel. This entire website rests on seven numbers supplied in a text document, and a reader holding the bottle can check them in a way we could not.

Corrections get made on the page, with the date. We would rather carry a visible correction than a quiet edit, and a site that never corrects anything is not a site that never made a mistake.

Contact →Disclaimer →The FAQ →

See the VapoCept packs

Two, three or six bottles, priced plainly, with a 60-day window that runs from purchase. Read the capsule count first, then decide.

Shipping is calculated at checkout. This site publishes no figure it was not given.

The process

How a page on this site gets written

  1. Establish what we actually have

    The first task on this build was not reading the brief but working out what kind of document it was. A typed ingredient list with no panel photograph is a different evidential object from a transcribed label, and every page carries that distinction.

  2. Compare the brief against the artwork

    The written brief and the supplied images are read side by side. Where they disagree the artwork wins and the disagreement is published. Five were found here, and the first of them is about what the product claims to do.

  3. List what is missing

    Anything a buyer would reasonably want that was not supplied goes on a list rather than being filled in from industry convention. On this build that list runs to ten items, and it includes the Other Ingredients line.

  4. Convert before comparing

    Every salt is converted to its base weight using published molecular weights before any comparison is made, because comparing a salt weight against a trial dose would overstate the product.

  5. Open every source

    No paper is cited that was not opened and read. Where a claim could not be verified, the page says so rather than using it.

  6. Choose the reading that favours the product

    Lowest studied dose, nominal salt ratio, no absorption penalty. If a conclusion survives all three it is not a conclusion about our method.

  7. Stop where our authority stops

    The claim page sets out the regulatory framework and declines to reach a verdict, because FDA has not reached one and we are not FDA.

  8. Send it for review

    Before a page goes live, Dr. Mary Cunningham, a neuropsychologist, reads it for accuracy and for how it treats memory, attention and safety. The page carries the reviewer’s name and the date it was revised.

The obvious question

Why a seller would publish this

A reasonable reader gets here and asks why a business that sells something would run the arithmetic that undercuts it. The answer is not that we are unusually virtuous.

  • The numbers are already public. This label publishes every milligram. Anyone with a calculator and a search engine can do what this site does, and a page that pretended otherwise would be caught by the first reader who tried.
  • A buyer who understands what they bought does not feel misled in month two. The 60-day window makes a disappointed buyer expensive.
  • Most people in this category are not looking for a promise. They are looking for someone who will tell them what is on the label, because almost nobody does.
  • The pages that would perform best on a conventional product site — invented testimonials, a countdown timer, a fabricated study count — are the ones we are least willing to write.

None of that makes the conflict disappear. It explains why the incentive runs less against honesty here than it might look, and it is offered as an explanation rather than as a reason to trust us.

There is also a specific reason on this build. A label that quantifies everything has done the hard and unusual thing. Writing a page that buried that under criticism would misrepresent the document we were given, and the scorecard reflects it: this product scores 9 on dose transparency and 1 on dose adequacy, and both scores are about the same seven numbers.

Colophon

Who made and checked this VapoCept page

Written byVapoCept Editorial Deskfor Vapoceptdaily, U.S. stocking partner
Reviewed byDr. Mary CunninghamNeuropsychologist
Revisedthe date moves when the page changes

Written from the seller’s panel, the front of the bottle and the sources cited on the page, then reviewed before publication. It is general information for adults and does not replace a conversation with your own clinician.

If your memory or concentration is changing, or you are on medicine for blood pressure or the heart, the first conversation is with your clinician, before the first VapoCept capsule.

VapoCept — 30 capsules, 30 days665.5 mg declared, 7 names · from $49 a bottleSee the packs